Abstract:Objective: To analyze the effects of lncRNA H19 on proliferation, invasion and radiotherapy sensitivity of brain glioma T98G cells and its mechanism. Methods: The differential expressions of lncRNA H19, miR-370-3p and RAF1 in glioma tissues and adjacent tissues were detected by real-time fluorescence quantitative PCR. The expression levels of lncRNA H19, miR-370-3p and RAF1 were detected after T98G cells were irradiated with X-ray (0, 2, 4, 6 Gy). T98G cells were transfected with H19 siRNA, miR-370-3p inhibitor and RAF1 siRNA plasmid, respectively, after 6 Gy X-ray irradiation, the effects of down-regulation of H19, miR-370-3p and RAF1 on the proliferation, invasion and apoptosis of T98G cells were detected by CCK-8, Transwell and flow cytometry, respectively. The target and correlation between lncRNA H19 and miR-370-3p, miR-370-3p and RAF1 were analyzed by miRcode, TargetScan and dual luciferase reporter gene assay. The effects of upregulated lncRNA H19 on the proliferation, invasion and radiotherapy sensitivity of T98G cells via miR-370-3p were examined. RT-qPCR and Western blot were used to detect the effect of lncRNA H19 on the expression of RAF1 via miR-370-3p. Results: The expressions of lncRNA H19 and RAF1 in glioma tissues were up-regulated (P<0.01), and the expression of miR-370-3p was down-regulated (P<0.01). The expressions of lncRNA H19 and RAF1 decreased after radiation in a dose dependent manner. The expression of miR-370-3p increased after radiation in a dose dependent manner. Downregulation of lncRNA H19 or RAF1 inhibited proliferation and invasion of T98G cells and enhanced radiotherapy sensitivity. LncRNA H19 targeted miR-370-3p and miR-370-3p targeted RAF1. Downregulation of miR-370-3p promoted the proliferation and invasion of T98G cells, and reduced the radiotherapy sensitivity. The up-regulation of lncRNA H19 promoted the proliferation and invasion of T98G cells through miR-370-3p, and reduced the radiotherapy sensitivity. Conclusion: LncRNA H19 regulated the proliferation, invasion and radiotherapy sensitivity of T98G cells through miR-370-3p/RAF1 axis.
徐华, 张海萍, 杨苗, 马蕾. LncRNA H19通过miR-370-3p/RAF1轴对脑胶质瘤T98G细胞增殖侵袭和放疗敏感性的影响及机制[J]. 河北医学, 2021, 27(12): 1937-1942.
XU Hua, et al. Effects of LncRNA H19 on Proliferation Invasion and Radiotherapy Sensitivity of Glioma T98G Cells Through MiR-370-3p/RAF1 Axis and the Mechanism. HeBei Med, 2021, 27(12): 1937-1942.
[1] 陈怡东,邱晓光.2018年脑胶质瘤放化疗进展[J].中华医学信息导报,2019,34(1):14. [2] 邢士军,王莉,张丽君.IVIM-MRI对人脑胶质瘤的病理分级及IDH1基因突变的评估价值[J].中国临床神经外科杂志,2020,25(12):10~13. [3] 曹美香,王奉淼,周素敏.同步高压氧治疗联合放化疗在脑胶质瘤术后患者中的应用[J].齐鲁护理杂志,2020,484(16):84~87. [4] Ding YM,Chan EC,Liu LC,et al.Long noncoding RNAs:Important participants and potential therapeutic targets for myocardial ischaemia reperfusion injury[J].Clin Exp Pharmacol Physiol,2020,47(11):1783~1790. [5] Shen Y,Peng X,Shen C.Identification and validation of immune-related lncRNA prognostic signature for breast cancer[J].Genomics,2020,112(3):2640~2646. [6] Wang C,Ke S,Li M,et al.Downregulation of LncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression[J].Molecular Genetics and Genomics,2020,295(1):251~260. [7] Zhang J,Li XY,Hu P,et al.lncRNA NORAD contributes to colorectal cancer progression by inhibition of miR-202-5p[J].Oncol Res,2018,26(9):1411~1418. [8] Fu Z,Chen C,Zhou Q,et al.LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9[J].Cancer Lett,2017,1(410):68~81. [9] Hua Q,Lv X,Gu X,et al.Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population[J].Mutagenesis,2016 ,31(5):531~538. [10] Sun H,Wang G,Peng Y,et al.H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells[J].Oncol Rep,2015,33(6):3045~3052. [11] 潘力雄,陈忠平,李永强,等.人脑胶质瘤细胞放射敏感性的实验研究[J].中国临床神经外科杂志,2004,9(4):283~285. [12] Liu S,Qiu J,Tang X,et al.LncRNA-H19 regulates cell proliferation and invasion of ectopic endometrium by targeting ITGB3 via modulating miR-124-3p[J].Exp Cell Res,2019,381(2):215~222. [13] Dang S,Malik A,Chen J,et al.LncRNA SNHG15 contributes to immuno-escape of gastric cancer through targeting miR141/PD-L1[J].Onco Targets Ther,2020 ,24(13):8547~8556. [14] Xiao Z,Ding N,Xiao G,et al.Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line[J].Anat Rec (Hoboken),2012,295(12):2122~2128. [15] Wu F,Zhou J.CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling[J].BMC Cancer,2019 ,19(1):1067~1109.